Chemical Works of Gedeon Richter. 

ft12,395
80
-ft175-1.39% Thursday 14:52

Statistics

Day High
7,468.11
Day Low
7,468.11
52W High
9,826.6
52W Low
7,278.73
Volume
-
Avg. Volume
9,290
Mkt Cap
2.31T
P/E Ratio
-
Dividend Yield
3.74%
Dividend
463.66

Upcoming

Dividends

3.74%Dividend Yield
Jun 25
ft509
Jun 24
ft431.98
Jun 23
ft390
Jun 22
ft225
Jun 21
ft225.32
10Y Growth
18.57%
5Y Growth
12.7%
3Y Growth
8.38%
1Y Growth
N/A

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.99
1.33
1.66
1.99
Expected EPS
N/A
Actual EPS
N/A

Financials

24.74%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.54TRevenue
628BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0QFP.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Gedeon Richter in various therapeutic areas.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Gedeon Richter's offerings, especially in women's healthcare and central nervous system drugs.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company that competes with Gedeon Richter in the generics market and in developing specialty medicines.
Merck
MRK
Mkt Cap298.84B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Gedeon Richter in several therapeutic areas.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie operates in the pharmaceuticals industry, focusing on immunology, oncology, neuroscience, and virology, areas where Gedeon Richter also has significant interests.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that compete with Gedeon Richter's product portfolio.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global healthcare leader that offers a broad range of pharmaceuticals, competing with Gedeon Richter in areas like central nervous system and cardiovascular diseases.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a science-led global healthcare company that competes with Gedeon Richter in developing and marketing medications and vaccines.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson is a diversified healthcare company that produces pharmaceuticals, medical devices, and consumer health products, competing across multiple segments with Gedeon Richter.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Gedeon Richter in developing new medicines in oncology, cardiovascular, renal & metabolism, and respiratory.

About

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. Additionally, it has a strategic research collaboration with FimmCyte AG for the development of first-in-class antibody, "FMC2', for the treatment of endometriosis. The company was founded in 1901 and is headquartered in Budapest, Hungary.
Show more...
CEO
Mr. Gabor Orban
Employees
10943
Country
GB
ISIN
HU0000123096

Listings

0 Comments

Share your thoughts

FAQ

What is Chemical Works of Gedeon Richter. stock price today?
The current price of 0QFP.LSE is ft12,395 HUF — it has decreased by -1.39% in the past 24 hours. Watch Chemical Works of Gedeon Richter. stock price performance more closely on the chart.
What is Chemical Works of Gedeon Richter. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chemical Works of Gedeon Richter. stocks are traded under the ticker 0QFP.LSE.
What is Chemical Works of Gedeon Richter. market cap?
Today Chemical Works of Gedeon Richter. has the market capitalization of 2.31T
When is the next Chemical Works of Gedeon Richter. earnings date?
Chemical Works of Gedeon Richter. is going to release the next earnings report on May 12, 2026.
What is Chemical Works of Gedeon Richter. revenue for the last year?
Chemical Works of Gedeon Richter. revenue for the last year amounts to 2.54T HUF.
What is Chemical Works of Gedeon Richter. net income for the last year?
0QFP.LSE net income for the last year is 628B HUF.
Does Chemical Works of Gedeon Richter. pay dividends?
Yes, 0QFP.LSE dividends are paid annual. The last dividend per share was 509 HUF. As of today, Dividend Yield (FWD)% is 3.74%.
How many employees does Chemical Works of Gedeon Richter. have?
As of April 10, 2026, the company has 10,943 employees.
In which sector is Chemical Works of Gedeon Richter. located?
Chemical Works of Gedeon Richter. operates in the Industrials sector.
When did Chemical Works of Gedeon Richter. complete a stock split?
The last stock split for Chemical Works of Gedeon Richter. was on July 23, 2013 with a ratio of 10:1.
Where is Chemical Works of Gedeon Richter. headquartered?
Chemical Works of Gedeon Richter. is headquartered in Budapest, GB.